The EPS projection of EXACT Sciences Corporation (NASDAQ:EXAS) for quarter ended 2016-09-30 is $-0.51. Last week, the EPS forecast was $-0.51 against target of $-0.51, a month earlier. Two months ago, this estimate was $-0.51 versus forecast of $-0.51 three months earlier, implying a deviation of 0%.
EXACT Sciences Corporation (NASDAQ:EXAS) stated that 18 days ago, its stock price was positively revised 0 times while negative revisions were 4.
In last week, the experts lowered EPS 0 times and increased EPS 0 times. In last 30, 120, 60 and 90 days, the experts upped revisions 0 , 2, 2, and 2, correspondingly.
EPS estimate downgrade for EXACT Sciences Corporation (NASDAQ:EXAS) in the preceding 30, 120, 60 and 90 days were 0, 3, 3, and 3, correspondingly.
EXACT Sciences Corporation (NASDAQ:EXAS) EPS target for the quarter closed 1 was $-0.51, based on 6 recommendations. As reported on 2016-05-03 the EPS was $-0.49. The change was $0.05, implying a percentage deviation of 9.26%. The projections showed a standard deviation of 0.01.
Quarterly Sales Estimates
EXACT Sciences Corporation (NASDAQ:EXAS) yearly sales prediction for the fiscal 2017 stands at $39.88 and the median estimate is at $40.34. Almost 3 analysts issued sales target.
Highest sales target is $40.9 while the lowest target is $38.4 showing standard deviation of 1.311%.
As many as 3 analysts have sales targets revised upside while 3 reduced sales estimates, implying a deviation of 1.726%.
Last month, 3 revised sales number projection on upside while 3 lowered the sales projections, implying a deviation of 1.726%.
A quarter ago, 3 hiked sales target and 3 reduced sales forecast. EXACT Sciences Corporation (NASDAQ:EXAS) announced that the deviation in forecast was 0.466%.
1 Chart Pattern Every Investor Should Know
This little-known pattern preceded moves of 578% in ARWR, 562% in LCI, 513% in ICPT, 439% in EGRX, 408% in ADDUS and more...